Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)
CUSIP: 03969K108
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,541,881
- Total 13F shares
- 34,766,158
- Share change
- +988,112
- Total reported value
- $1,018,651,387
- Price per share
- $29.30
- Number of holders
- 62
- Value change
- +$28,894,471
- Number of buys
- 40
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969K108:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
8.6%
|
10,542,790
|
$318,814,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
4.7%
|
5,723,182
|
$173,069,000 | — | 30 Jun 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.8%
|
4,673,850
|
$141,337,000 | — | 30 Jun 2020 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.2%
|
3,979,292
|
$120,334,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
1,566,574
|
$47,372,000 | — | 30 Jun 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
1.1%
|
1,289,360
|
$38,990,000 | — | 30 Jun 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.95%
|
1,165,184
|
$35,235,000 | — | 30 Jun 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.87%
|
1,066,540
|
$32,252,000 | — | 30 Jun 2020 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.69%
|
844,680
|
$25,543,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.43%
|
527,127
|
$15,941,000 | — | 30 Jun 2020 | |
| Polar Capital LLP |
13F
|
Company |
0.37%
|
450,000
|
$13,608,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.31%
|
377,581
|
$11,418,000 | — | 30 Jun 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.23%
|
278,019
|
$8,407,000 | — | 30 Jun 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
186,580
|
$5,642,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
171,914
|
$5,199,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
152,262
|
$4,604,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
128,330
|
$3,881,000 | — | 30 Jun 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
77,364
|
$2,339,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
68,246
|
$2,064,000 | — | 30 Jun 2020 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
52,053
|
$1,574,000 | — | 30 Jun 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.04%
|
50,000
|
$1,512,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.04%
|
43,955
|
$1,329,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
35,255
|
$1,066,000 | — | 30 Jun 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
33,089
|
$1,000,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
27,700
|
$838,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
25,939
|
$784,000 | — | 30 Jun 2020 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
21,300
|
$644,000 | — | 30 Jun 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
20,996
|
$635,000 | — | 30 Jun 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
20,827
|
$630,000 | — | 30 Jun 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
20,474
|
$619,000 | — | 30 Jun 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
16,000
|
$484,000 | — | 30 Jun 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
14,291
|
$432,000 | — | 30 Jun 2020 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
13,718
|
$415,000 | — | 30 Jun 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
12,422
|
$376,000 | — | 30 Jun 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
11,592
|
$351,000 | — | 30 Jun 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
11,031
|
$334,000 | — | 30 Jun 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.01%
|
9,546
|
$289,000 | — | 30 Jun 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
9,400
|
$284,000 | — | 30 Jun 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
8,142
|
$246,000 | — | 30 Jun 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.01%
|
7,500
|
$227,000 | — | 30 Jun 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
5,797
|
$175,000 | — | 30 Jun 2020 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0%
|
5,342
|
$161,542 | — | 30 Jun 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,725
|
$143,000 | — | 30 Jun 2020 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
3,777
|
$114,216 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3,776
|
$114,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3,573
|
$108,000 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,188
|
$96,000 | — | 30 Jun 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,110
|
$94,000 | — | 30 Jun 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,011
|
$91,000 | — | 30 Jun 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,584
|
$48,000 | — | 30 Jun 2020 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q3 2020
As of 30 Sep 2020,
Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,766,158 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, FMR LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., Vivo Capital, LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and Omega Fund Management, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
55
Q3 2020 holders
62
Holder diff
7
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.